Related Experiment Video
Updated: Jul 4, 2025

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Middle Molecular Uremic Toxin and Blood Purification Therapy
1Tsuchiya General Hospital, 3-30 Nakajima-cho Naka-ku, Hiroshima 730-8655, Japan.
Abstract:
The purpose of blood purification therapy is to remove uremic toxins, and middle molecules (MMs) are a specific target. An MM is defined as a solute that passes through the glomerulus with a molecular weight in the range of 0.5-58 kDa, and new classifications of "small-middle 0.5-15 kDa," "medium-middle 15-25 kDa," and "large-middle 25-58 kDa" were proposed. In Japan, the removal of α1-microglobulin (αMG) in the large-middle range has been the focus, but a new theory of removal has been developed, emphasizing the antioxidant effect of αMG as a physiological function. Clinical proof of this mechanism will lead to further development of blood purification therapies.
Insights
Blood purification therapy removes uremic toxins, targeting middle molecules (MMs). New research highlights the antioxidant role of alpha1-microglobulin (aMG), a large-middle molecule, potentially advancing treatment strategies.
Area of Science:
- Nephrology
- Biochemistry
- Medical Technology
Background:
- Blood purification therapy aims to eliminate uremic toxins.
- Middle molecules (MMs) are key targets, classified by molecular weight (0.5-58 kDa).
- New classifications include small-middle (0.5-15 kDa), medium-middle (15-25 kDa), and large-middle (25-58 kDa) MMs.
Purpose of the Study:
- To discuss the role of middle molecules in blood purification.
- To introduce new classifications for middle molecules.
- To explore the physiological function of alpha1-microglobulin (aMG) beyond toxin removal.
Main Methods:
- Literature review on middle molecule classification and removal.
- Discussion of emerging theories on aMG function.
- Analysis of current blood purification strategies focusing on large-middle molecules.
Main Results:
- Proposed new classifications for middle molecules based on size.
- Highlighted the antioxidant properties of alpha1-microglobulin (aMG).
- Shift in focus from solely removal to understanding the physiological roles of MMs.
Conclusions:
- Understanding the antioxidant effect of aMG is crucial.
- Further clinical validation of aMG's physiological function is needed.
- This research may drive advancements in blood purification therapies.
Related Concept Videos
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Drug Elimination by Renal Route: Tubular Secretion
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Filtration and Urine Formation
Drug Elimination by Renal Route: Tubular Reabsorption
Renal Drug Excretion: Tubular Secretion

